| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 May 2024 | 9 May 2024 |
| NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 inter alia to consider and approve the Audited Financial Results for the quarter and year ended March 31 2024 Audited Financial Results for the quarter and year ended 31st March, 2024 (As Per BSE Announcement Dated on 27.05.2024) | ||
| Board Meeting | 14 Feb 2024 | 2 Feb 2024 |
| NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Consider the Unaudited Results for the quarter and nine months ended 31st December 2023 and Interim Dividend for the Financial year 2023-24 if any outcome of Board Meeting Unaudited Financial Results for the quarter and nine months ended 31st December, 2023 (As Per BSE Announcement Dated 14.02.2024) | ||
| Board Meeting | 14 Nov 2023 | 3 Nov 2023 |
| NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve The Unaudited Financial Results for the quarter and half year ended 30th September 2023 and declaration of second interim dividend if any Outcome of the Board Meeting Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September 2023 prepared under Indian Accounting Standards (IND-AS) and as per Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time (Listing Regulations) along with Limited Review Report of the Statutory Auditors. Please find enclosed herewith a copy of the same for your information. Outcome of the Board Meeting (As per BSE Announcement Dated on 14/11/2023) Declared second interim dividend of Rs.1.25 (Rupees one and twenty five paise only) (62.50 %) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2023-24. The date for taking on record of its shareholders eligible for the purpose of payment ofsecond interim dividend i.e.,record date is fixed as Friday, the 24th day of November 2023. The payment of said interim dividend will start from 1st December 2023. (As Per BSE Announcement Dated on 15.11.2023) | ||
| Board Meeting | 9 Aug 2023 | 31 Jul 2023 |
| NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve Unaudited Financial Results for the quarter ended 30th June 2023 and to consider interim dividend for the Financial Year 2023-24 if any. Board approved:- 1. Declared interim dividend of Rs.7/- (Rupees Seven only) (350 %) per equity share of Rs.2/- (Rupees two only) each for the financial year 2023-24. The date for taking on record of its shareholders eligible for the purpose of payment of interim dividend i.e., record date is fixed as Tuesday, the 22nd day of August 2023. The payment of said interim dividend will start from 30th August 2023. 2. Notice of the 40th Annual General Meeting and the Board had authorised Sri V.C. Nannapaneni, Managing Director for finalizing the date, time, book closure dates and mode of conducting of Annual General Meeting for the financial year 2022-23. 3. Amendment of Materiality Policy of the Company i.e., NATCOs Policy for determination of Materiality of an Event or Information and copy of the policy will be made available on the website of the Company. 4. Incorporate a Subsidiary Company in United Kingdom with an investment up to an amount not exceeding USD 3,000,000 (United State Dollar Three Million only). Unaudited Financial Results for the quarter ended 30th June, 2023 Outcome of Board Meeting (As Per BSE Announcement Dated on 09.08.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
